Skip to main content
Signal8

Aldeyra Therapeutics, Inc. (ALDX) Form 8-K — Nov 17, 2026

$ALDXForm 8-KItems 3.01Filed Nov 17, 2026, 4:50 PM ET0001193125-26-465667Original filing

Aldeyra Therapeutics received a Nasdaq notice on November 17, 2026 because its stock closed below the $1.00 minimum bid price for 30 consecutive business days. The notice has no immediate effect on listing, and the company has until May 17, 2027 to regain compliance by closing at $1.00 or higher for 10 consecutive business days.

Key figures

Cure period days
180
Compliance deadline
2027-05-17
Minimum bid price usd
1
Consecutive days required to regain compliance
10

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.